{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:50:53Z","timestamp":1781614253892,"version":"3.54.5"},"reference-count":38,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Union","award":["101102733"],"award-info":[{"award-number":["101102733"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background\/Objectives: Human papillomavirus (HPV) is a recognized cause of cervical cancer and is associated with several other malignancies, including those affecting the vagina, vulva, anus, penis, and head and neck. The introduction of the HPV vaccine has enabled the prevention of HPV-related cancers. This study aimed to determine the HPV vaccination coverage and examine trends in HPV vaccination in Croatia from 2016 to 2023 in the context of the national vaccination program. Methods: This retrospective study analyzed the aggregated school doctors\u2019 data from 2016 to 2023. HPV vaccination coverages within the 2000\u20132008 birth cohorts were assessed based on the number of doses administrated, sex, and vaccination schedule, while for the trend analysis joinpoint regression was used. The vaccination coverage between sexes was tested using the chi-square test for trends and their ratio was calculated. Results: The HPV full-dose vaccination coverage increased significantly among the observed birth cohorts, from 4.49% in 2000 to 36.88% in 2008, with an APC = 33.97 and 95% CI: 29.37\u201342.43 (females from 7.74% to 44.98%, males from 1.44% to 29.14%). The highest recorded vaccination coverage was in the one-dose category (2008 female\u201452.78%). The vaccination coverage of females was significantly higher than that of males (the chi-square for the linear trend = 659.59, p &lt; 0.001) and the female\u2013male ratio decreased from 5.39 in 2000 to 1.54 in 2008. Conclusions: In Croatia, HPV vaccination coverage has increased since the introduction of the national HPV vaccination program. This positive trend was present in both sexes, and the rate ratio between female and male cohorts decreased.<\/jats:p>","DOI":"10.3390\/vaccines13040410","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T06:50:27Z","timestamp":1744699827000},"page":"410","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Trends Towards Enhanced Rates and Sex Parity in HPV Vaccination in Croatia (2016\u20132023)"],"prefix":"10.3390","volume":"13","author":[{"given":"Lucija","family":"Raic","sequence":"first","affiliation":[{"name":"Division for Health Informatics and Biostatistics, Croatian Institute of Public Health, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Pavic Simetin","sequence":"additional","affiliation":[{"name":"Division for School Medicine, Mental Health and Addiction Prevention, Croatian Institute of Public Health, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9398-7403","authenticated-orcid":false,"given":"Emanuel","family":"Bradasevic","sequence":"additional","affiliation":[{"name":"Division for Health Informatics and Biostatistics, Croatian Institute of Public Health, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antea","family":"Jezidzic","sequence":"additional","affiliation":[{"name":"Division for Health Informatics and Biostatistics, Croatian Institute of Public Health, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Nemeth Blazic","sequence":"additional","affiliation":[{"name":"Department for HIV, Sexually Transmitted and Blood-Borne Infections, Croatian Institute of Public Health, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2336-0861","authenticated-orcid":false,"given":"Tamara","family":"Poljicanin","sequence":"additional","affiliation":[{"name":"Zagreb County Health Center, 10430 Samobor, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4167\/jbv.2020.50.3.158","article-title":"Overview of the Efficacy of Human Papillomavirus Virus Vaccines","volume":"50","author":"Seong","year":"2020","journal-title":"J. Bacteriol. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.vaccine.2006.06.015","article-title":"Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6\/11 disease","volume":"24","author":"Lacey","year":"2006","journal-title":"Vaccine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide Burden of Cancer Attributable to HPV by Site, Country and HPV Type","volume":"141","author":"Plummer","year":"2017","journal-title":"Int. J. Cancer"},{"key":"ref_4","unstructured":"(2024, January 30). Factsheet about Human Papillomavirus. Available online: https:\/\/www.ecdc.europa.eu\/en\/human-papillomavirus\/factsheet."},{"key":"ref_5","unstructured":"Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J.J., G\u00f3mez, D., Mu\u00f1oz, J., Bosch, F.X., and de Sanjos\u00e9, S. (2024, January 30). Human Papillomavirus and Related Diseases Report WORLD 2023 March. Available online: https:\/\/hpvcentre.net\/statistics\/reports\/XWX.pdf."},{"key":"ref_6","unstructured":"(2024, February 05). Nacionalni dan Borbe Protiv Raka Vrata Maternice\u2014Epidemiolo\u0161ki Podaci|Hrvatski Zavod za Javno Zdravstvo. Available online: https:\/\/www.hzjz.hr\/sluzba-epidemiologija-prevencija-nezaraznih-bolesti\/nacionalni-dan-borbe-protiv-raka-vrata-maternice-epidemioloski-podaci\/."},{"key":"ref_7","unstructured":"(2024, February 01). Bilten Incidencija raka u Hrvatskoj 2020. Available online: https:\/\/www.hzjz.hr\/aktualnosti\/bilten-incidencija-raka-u-hrvatskoj-2020-godine\/."},{"key":"ref_8","unstructured":"Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J.J., G\u00f3mez, D., Mu\u00f1oz, J., Bosch, F.X., and de Sanjos\u00e9, S. (2024, July 03). Human Papillomavirus and Related Diseases Report CROATIA. Available online: https:\/\/hpvcentre.net\/datastatistics.php."},{"key":"ref_9","unstructured":"World Health Organization (2020). Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem, World Health Organization. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240014107."},{"key":"ref_10","unstructured":"European Commission (2022). Europe\u2019s Beating Cancer Plan: Communication from the Commission to the European Parliament and the Council, European Commission."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Nemeth Bla\u017ei\u0107, T., Bo\u017ei\u010devi\u0107, I., Kosanovi\u0107 Li\u010dina, M.L., \u0160tulhofer, A., and Nola, I.A. (2023). Self-reported HPV vaccination status and HPV vaccine hesitancy in a nationally representative sample of emerging adults in Croatia. Front. Public Health., 11.","DOI":"10.3389\/fpubh.2023.1182582"},{"key":"ref_12","unstructured":"(2024, April 05). Provedbeni Program Cijepljenja za 2024. Available online: https:\/\/www.hzjz.hr\/sluzba-epidemiologija-zarazne-bolesti\/provedbeni-program-cijepljenja-za-2024-godinu\/."},{"key":"ref_13","unstructured":"(2024, February 05). Cijepljenje Protiv Humanog Papiloma Virusa (HPV)|Hrvatski Zavod za Javno Zdravstvo. Available online: https:\/\/www.hzjz.hr\/aktualnosti\/cijepljenje-protiv-humanog-papiloma-virusa-hpv\/."},{"key":"ref_14","unstructured":"(2024, April 05). Hrvatski Zdravstveno-Statisti\u010dki Ljetopis za 2020.\u2014Tabli\u010dni Podaci|Hrvatski Zavod za Javno Zdravstvo. Available online: https:\/\/www.hzjz.hr\/periodicne-publikacije\/hrvatski-zdravstveno-statisticki-ljetopis-za-2020-tablicni-podaci\/."},{"key":"ref_15","unstructured":"(2024, March 19). HRVATSKI ZDRAVSTVENO-STATISTI\u010cKI LJETOPIS ZA 2021. Available online: https:\/\/www.hzjz.hr\/cat\/hrvatski-zdravstveno-statisticki-ljetopis\/."},{"key":"ref_16","unstructured":"(2024, April 05). HRVATSKI ZDRAVSTVENO-STATISTI\u010cKI LJETOPIS ZA 2022. Available online: https:\/\/www.hzjz.hr\/cat\/hrvatski-zdravstveno-statisticki-ljetopis\/."},{"key":"ref_17","unstructured":"Hrvatsko dru\u0161tvo za \u0161kolsku i sveu\u010dili\u010dnu medicinu (2024, March 19). Preporuke Hrvatskog dru\u0161tva za \u0161kolsku i sveu\u010dili\u0161nu medicinu HLZ o organizaciji cijepljenja protiv HPV infekcije. Available online: https:\/\/zzjzpgz.hr\/wp-content\/uploads\/2023\/02\/Preporuke-HDSSM-za-HPV-2023.pdf."},{"key":"ref_18","unstructured":"(2024, January 30). HPV Vaccine Administration|CDC, Available online: https:\/\/www.cdc.gov\/vaccines\/vpd\/hpv\/hcp\/administration.html."},{"key":"ref_19","unstructured":"(2024, January 30). Meeting of the Strategic Advisory Group of Experts on Immunization, April 2022: Conclusions and Recommendations. Available online: https:\/\/www.who.int\/publications\/i\/item\/who-wer9724-261-276."},{"key":"ref_20","unstructured":"(2025, March 22). Joinpoint Regression Program, Available online: https:\/\/surveillance.cancer.gov\/joinpoint\/."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat. Med."},{"key":"ref_22","unstructured":"(2024, February 08). OpenEpi-Dose Response: Chi Square for Trend. Available online: https:\/\/www.openepi.com\/DoseResponse\/DoseResponse.htm."},{"key":"ref_23","unstructured":"(2024, February 06). Immunization, Vaccines and Biologicals. Available online: https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/diseases\/human-papillomavirus-vaccines-(HPV)\/hpv-clearing-house\/hpv-dashboard."},{"key":"ref_24","unstructured":"(2025, March 23). Human Papillomavirus (HPV) Vaccination Coverage. Available online: https:\/\/immunizationdata.who.int\/global\/wiise-detail-page\/human-papillomavirus-(hpv)-vaccination-coverage."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"106399","DOI":"10.1016\/j.ypmed.2020.106399","article-title":"HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010\u20132019","volume":"144","author":"Bruni","year":"2021","journal-title":"Prev. Med."},{"key":"ref_26","unstructured":"(2024, March 19). Budi mRAK! Izbjegni Rak! Sve o HPV-u i Prevenciji. Available online: https:\/\/budi-mrak.com\/."},{"key":"ref_27","unstructured":"(2024, March 19). Spolno Zdravlje. Available online: https:\/\/spolnozdravlje.hr\/."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"100189","DOI":"10.1016\/j.pvr.2019.100189","article-title":"School-Based Human Papillomavirus Vaccination Program for Increasing Vaccine Uptake in an Underserved Area in Texas","volume":"8","author":"Kaul","year":"2019","journal-title":"Papillomavirus Res."},{"key":"ref_29","first-page":"191","article-title":"HPV vaccination coverage in the European Region","volume":"74","author":"Borowska","year":"2024","journal-title":"Nowotw. J. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.vaccine.2019.11.081","article-title":"Human papillomavirus vaccination coverage, policies, and practical implementation across Europe","volume":"38","author":"Thilly","year":"2020","journal-title":"Vaccine"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Rejza, M., Rylewicz, K., Lewandowska, M., Gross-Tyrkin, K., \u0141opi\u0144ski, G., Barwi\u0144ska, J., Majcherek, E., Szymu\u015b, K., Klein, P., and Plagens-Rotman, K. (2022). HPV Vaccination among Polish Adolescents\u2014Results from POLKA 18 Study. Healthcare, 10.","DOI":"10.3390\/healthcare10122385"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1080\/21645515.2018.1564436","article-title":"HPV vaccination in a context of public mistrust and uncertainty: A systematic literature review of determinants of HPV vaccine hesitancy in Europe","volume":"15","author":"Karafillakis","year":"2019","journal-title":"Hum. Vaccin Immunother."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Alarc\u00e3o, V., and Zdravkova, B. (2022). Attitudes and Practices towards HPV Vaccination and Its Social Processes in Europe: An Equity-Focused Scoping Review. Societies, 12.","DOI":"10.3390\/soc12050131"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.13112\/pc.508","article-title":"HPV vaccination in the Republic of Croatia","volume":"62","author":"Posavec","year":"2018","journal-title":"Paediatr. Croatiaca"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/pubmed\/fdaa201","article-title":"Educational intervention for increasing knowledge of human papillomavirus and vaccination amongst parents of first year high school students in Croatia","volume":"44","author":"Belavic","year":"2022","journal-title":"J. Public Health"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"djx187","DOI":"10.1093\/jnci\/djx187","article-title":"Real-world Data for Clinical Evidence Generation in Oncology","volume":"109","author":"Khozin","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Liu, F., and Panagiotakos, D. (2022). Real-world data: A brief review of the methods, applications, challenges and opportunities. BMC Med. Res. Methodol., 22.","DOI":"10.1186\/s12874-022-01768-6"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"30519","DOI":"10.2807\/1560-7917.ES.2017.22.17.30519","article-title":"Immunisation Information Systems\u2014Useful tools for monitoring vaccination programmes in EU\/EEA countries, 2016","volume":"22","author":"Derrough","year":"2017","journal-title":"Eurosurveillance"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/4\/410\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:14:41Z","timestamp":1760030081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/4\/410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["vaccines13040410"],"URL":"https:\/\/doi.org\/10.3390\/vaccines13040410","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]}}}